These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Zamora MR; Warner ML; Tuder R; Schwarz MI Medicine (Baltimore); 1997 May; 76(3):192-202. PubMed ID: 9193454 [TBL] [Abstract][Full Text] [Related]
6. Infection in systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a potential key to improve outcomes. Li M; Bai W; Wang Y; Song L; Zhang S; Zhao J; Wu C; Li M; Tian X; Zeng X Clin Rheumatol; 2023 Jun; 42(6):1573-1584. PubMed ID: 36797549 [TBL] [Abstract][Full Text] [Related]
7. Diffuse alveolar hemorrhage secondary to sarcoidosis. Diaz-Menindez M; Sullivan MM; Butendieck RR; Abril A; Majithia V; Wang B; Berianu F Clin Rheumatol; 2023 Jun; 42(6):1701-1704. PubMed ID: 36847928 [TBL] [Abstract][Full Text] [Related]
8. Alveolar Hemorrhage in Vasculitis (Primary and Secondary). Nasser M; Cottin V Semin Respir Crit Care Med; 2018 Aug; 39(4):482-493. PubMed ID: 30404115 [TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Klemmer PJ; Chalermskulrat W; Reif MS; Hogan SL; Henke DC; Falk RJ Am J Kidney Dis; 2003 Dec; 42(6):1149-53. PubMed ID: 14655185 [TBL] [Abstract][Full Text] [Related]
13. Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity. Schnabel A; Reuter M; Csernok E; Richter C; Gross WL Eur Respir J; 1999 Jul; 14(1):118-24. PubMed ID: 10489838 [TBL] [Abstract][Full Text] [Related]
14. Lung vasculitis and alveolar hemorrhage: pathology. Fishbein GA; Fishbein MC Semin Respir Crit Care Med; 2011 Jun; 32(3):254-63. PubMed ID: 21674412 [TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Risk Factors of Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: a Systematic Review and Meta-Analysis Based on Observational Studies. Xu T; Zhang G; Lin H; Xie Y; Feng Y; Zhang X; Dong G Clin Rev Allergy Immunol; 2020 Dec; 59(3):295-303. PubMed ID: 31440948 [TBL] [Abstract][Full Text] [Related]
16. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Kwok SK; Moon SJ; Ju JH; Park KS; Kim WU; Cho CS; Kim HY; Park SH Lupus; 2011 Jan; 20(1):102-7. PubMed ID: 20956464 [TBL] [Abstract][Full Text] [Related]
17. Risk factors and outcomes of immune and non-immune causes of diffuse alveolar hemorrhage: a tertiary-care academic single-center experience. Bhushan A; Choi D; Maresh G; Deodhar A Rheumatol Int; 2022 Mar; 42(3):485-492. PubMed ID: 33782747 [TBL] [Abstract][Full Text] [Related]
18. Risk factors of diffuse alveolar hemorrhage in Chinese patients with systemic lupus erythematosus. Xu L; Yang R; Cao Y; Wang M; Yang X Sci Rep; 2023 Dec; 13(1):22381. PubMed ID: 38104153 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis. Jiang M; Chen R; Zhao L; Zhang X Arthritis Res Ther; 2021 Feb; 23(1):57. PubMed ID: 33593433 [TBL] [Abstract][Full Text] [Related]